Home > Back to Publisher > Report Information

Healthcare & Pharmaceuticals in Latin America - A guide to the markets and regulations

Urch Publishing
September 1, 2011
90 Pages - SKU: URC6556462

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Brazil

Although Latin America offers substantial business opportunities for companies, it is a volatile region in economic terms. There is considerable risk involved in investing in the region and companies need to be fully aware of past economic crises and their causes before becoming involved. Latin America continues to be a region of promising opportunities for commercial pharmaceutical organisations. The region represents a growing consumer base for the drug industry as by 2020 the regional population may be as high as 687 million.

The Latin American pharmaceutical market is now worth $45bn and multinational companies consider success in Brazil and Mexico as essential.

Healthcare & Pharmaceuticals in Latin America - A guide to the markets and regulations provides an excellent overview of the healthcare and pharmaceutical market in 19 Latin American countries.

This 40,000 word report, from URCH Publishing, will provide the reader with an excellent review of the healthcare systems, politics, regulatory framework, major companies and key issues affecting the healthcare sector.

Some of the main issues concerning pharmaceutical companies operating in the region include:

Intellectual Property: Laws on intellectual property remain weak or are not enforced in a number of countries, leading legally ambiguous products on the market.

Generics: Regional governments are making serious attempts to encourage the use of generics (in the past the term bioequivalence was interpreted differing across countries) and Indian companies in particular have made headway into the major markets.

R&D: Companies are finding Latin America an attractive centre for R&D. There are currently an estimate 4,000 clinical trials being conducted. High enrolment rates, lower labour costs and improving regulation have estimated the growth in outsourcing.

Political Situation: Unsettling for multinational companies is the political shift to the left in some countries. However, a number of countries are working to introduce universal healthcare coverage which in turn could create excellent long term opportunities.

Key features of the report:

Overview of healthcare systems in 19 Latin American countries
Review of the pharmaceutical market and major companies operating in each country
Brief guide to the relevant regulatory structure with comment on intellectual property issues.
Evaluation of the role of the generics in the domestic market
This report can help you:
Review the key political and government structures that influence business in the region
Understand the distinct characteristics of the Latin American pharmaceutical market
Consider how increased democracy will affect healthcare systems in relation to inequality and essential medicines
Gain insight into how generics are being promoted by a number of governments
Plan market strategy for successful entry and operation in the region

Executive Summary
Chapter 1: Characteristics of Latin America: Characterising Latin America; Investment in Latin America; The changing political situation in Latin America; Politics and healthcare in Latin America; The Organization of American States
Chapter 2: The Latin American healthcare environment: Approach to Latin American healthcare policy; Population trends; Implications of Latin American healthcare reform for the pharmaceutical industry; The Latin American pharmaceutical markets; Latin America and generics; Intellectual property; Essential medicines; Compulsory licensing; Clinical trials
Chapter 3: Argentina - Healthcare & Pharmaceuticals: Healthcare system; The pharmaceutical market; The pharmaceutical industry; Regulatory; Case study: Indian pharmaceutical companies invest in Argentina; Generics; Intellectual property issues; Clinical trials
Chapter 4: Belize: Healthcare system; Pharmaceutical market
Chapter 5: Bolivia: Healthcare system; Pharmaceutical market; Regulations
Chapter 6: Brazil: Healthcare system; The pharmaceutical market; The domestic pharmaceutical industry; Regulatory; Generics; Intellectual property; Clinical trials; Access to medicines
Chapter 7: Chile: Healthcare system; The pharmaceutical market; The pharmaceutical industry; Generics; Regulatory; Clinical trials
Chapter 8: Colombia: Healthcare system; The pharmaceutical market; The pharmaceutical industry; Intellectual property issues; Generics; Regulatory; Clinical trials
Chapter 9: Costa Rica: Healthcare system; Pharmaceutical market; Pricing; Regulations; Intellectual property
Chapter 10: Ecuador: Healthcare system; Pharmaceutical market; Intellectual property
Chapter 11: El Salvador: Healthcare system; Pharmaceutical market; Generics
Chapter 12: Guatemala: Healthcare system; Pharmaceutical market; Generics; Intellectual property issues
Chapter 13: Honduras: Healthcare system; Pharmaceutical market
Chapter 14: Mexico: Healthcare system; The pharmaceutical market; Generics; Similares; Pharmaceutical supply; Multinational pharmaceutical company presence; Clinical trials; Intellectual property issues; Illegal drug importation
Chapter 15: Nicaragua: Healthcare system; Pharmaceutical market
Chapter 16: Panama: Healthcare system; Pharmaceutical market
Chapter 17: Paraguay: Healthcare system; Pharmaceutical market; Pricing; Regulatory; Intellectual property
Chapter 18: Peru: Healthcare system; Pharmaceutical market; Pricing; Generics; Regulations; Clinical trials
Chapter 19: Uruguay: Healthcare system; Pharmaceutical market; Regulatory; Pricing
Chapter 20: Venezuela: Healthcare system; Pharmaceutical market; Case study: Pfizer Venezuela; Generics; Intellectual property issues; Counterfeits; About URCH Publishing
List of Figures: Figure 1.1: Gross national income per capita (PPP international $); Figure 1.2: Healthcare spending as percent of GDP; Figure 1.3: Life expectancy in Latin America (by country); Figure 2.1: Latin America - population growth; Figure 2.2: Latin American pharmaceutical market split (2011); Figure 2.3: Leading pharmaceutical markets in Latin America (2011); Figure 2.4: Emerging pharmaceutical markets in Latin America (2011); Figure 2.5: Regional split of Phase III clinical trials (2011); Figure 3.1: Density of the Health Workforce in Argentina; Figure 6.1: Phase III trials by Country (2011); Figure 6.2: Phase II trials by Country (2011); Figure 7.1: Pharmaceutical Market in Chile; Figure 8.1: Growth of Colombian Pharmaceutical Market; Figure 9.1: Costa Rica: Pharmaceutical imports by country; Figure 9.2: Costa Rica: Pharmaceutical exports by country; Figure 12.1: Innovator versus Generic Price Class Comparison in Guatemala; Figure 14.1: Employment in the Mexican Pharmaceutical Industry; Figure 14.2: Share of Mexican Pharmaceutical Market; Figure 18.1: Leading causes of mortality in Peru; Figure 18.2: Mortality rate for communicable diseases in Peru; Figure 19.1: Uruguayan pharmaceutical sector exports; Figure 19.2: Uruguayan pharmaceutical sector imports
List of Tables: Table 1.1: Member countries of the OAS; Table 2.1: Ranbaxy in Latin America; Table 6.1: ANVISA regulations; Table 14.1: Pharmaceutical product types in Mexico

More Brazil Manufacturing, Packaging & Detailing Reports

Freedonia Focus on Pharmaceutical Packaging: Brazil by Freedonia Focus
This report discusses pharmaceutical packaging in Brazil for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; market overview; ...

The Outlook for Pharmaceuticals in Brazil, Russia, India & China (pdf/xls) by Espicom Healthcare Intelligence
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist ...

The Pharmaceutical Market: Brazil (pdf/xls) by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...

Pharmaceuticals – Brazil – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Brazil by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) ...

See all reports like this >>

More Brazil Reports

D&B Country RiskLine Report: Brazil by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...

D&B Country Report: Brazil by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report Brazil February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the ...

See all reports like this >>

Healthcare & Pharmaceuticals in Latin America - A guide to the markets and regulations

Share this report

Other tasks

Research Assistance

Related Markets

Manufacturing, Packaging & Detailing Reports

Free Alert Me service